Podcast terbaik Emergency Medicine Residents Association (2024)

1
Transition to Attending-hood 23:15

1d ago23:15

23:15

The transition from being a resident to an attending may be daunting for some. But have no fear, EMRA*Cast host Lizzii Le sits down with Gus Garmel, an Adjunct Clinical Professor of EM at Stanford University, author of multiple books on clinical education, to discuss this topic.

1
NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity. 21:26

4d ago21:26

21:26

Jose Figueroa is an associate professor of health policy and management at the Harvard T.H. Chan School of Public Health and an assistant professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. McWilliams and S.B. Dusetzina. Affordability of Health Care in the United…

1
Views from Program Leadership 24:34

5d ago24:34

24:34

Students navigating the ERAS Application Cycle - or any residency application process - face a lot of stress and anxiety. Knowing the answer to every possible question is difficult, but having individuals with expertise in your corner is beneficial. Dr. Arlene Chung, current Vice Chair of Academic Affairs at the University of Vermont and previous P…

1
NEJM Interview: Jean Nachega on the mpox Public Health Emergency of International Concern. 9:20

11d ago9:20

9:20

Jean Nachega is an associate professor of infectious diseases and microbiology and of epidemiology at the University of Pittsburgh School of Public Health and a professor of medicine at Stellenbosch University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.B. Nachega and Others. Mpox in Pregnancy — Risks, Ve…

1
Navigating Leadership in Emergency Medicine 16:33

15d ago16:33

16:33

Being a leader in emergency medicine, whether in the department or on the administrative side, is easier said than done. So, what are the skills a good leader should have, and what practices should they absolutely avoid? In this episode, host Masood Mohammed (@DocMooseEM) sits down with emergency medicine physician Dr. Azita Hamedani (@ahamedani) a…

1
NEJM Interview: Jonathan Oberlander on the implications of the 2024 U.S. elections for health care reform. 8:47

18d ago8:47

8:47

Jonathan Oberlander is a professor of social medicine and of health policy and management at the University of North Carolina at Chapel Hill. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Oberlander. Health Care Reform and the 2024 U.S. Elections — Low Visibility, High Stakes. N Engl J Med 2024;391:1169-117…

1
NEJM Interview: Abigail Cutler on providing training in abortion care to Ob/Gyn residents amid legal restrictions. 10:12

25d ago10:12

10:12

Abigail Cutler is an assistant professor and associate residency program director in the Department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine and Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Cutler and E. Hartenbach. Dobbs Revisited — Addressing Effects…

1
NEJM Interview: Charles Weijer on the potential benefits and ethical challenges associated with pragmatic and cluster RCTs. 11:56

1M ago11:56

11:56

Charles Weijer is a professor in the Departments of Medicine and Philosophy at Western University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C. Weijer and M. Taljaard. Ethical Challenges Associated with Pragmatic and Cluster RCTs. N Engl J Med 2024;391:969-971.…

1
Acetaminophen Overdose: Updated Guidance 20:01

1M ago20:01

20:01

Acetaminophen is widely available over the counter in the United States, increasing the risk of overdose (both acute and chronic). Several factors contribute to the complexity of managing this tricky condition in the emergency department, but until recently, there has been no true standardized approach. Guidance issued in 2023 aims to establish a h…

1
NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma 2:58

1M ago2:58

2:58

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors 2:56

1M ago2:56

2:56

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma 3:11

1M ago3:11

3:11

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer 3:44

1M ago3:44

3:44

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma 3:41

1M ago3:41

3:41

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer 3:25

1M ago3:25

3:25

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer 3:23

1M ago3:23

3:23

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer 2:21

1M ago2:21

2:21

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer 2:50

1M ago2:50

2:50

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Ponsegromab in Cancer Cachexia 2:37

1M ago2:37

2:37

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM Interview: Benjamin Chrisinger on proposed changes to the Supplemental Nutrition Assistance Program and other options for promoting improved health. 9:11

1M ago9:11

9:11

Benjamin Chrisinger is an assistant professor in the Department of Community Health at Tufts University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. B.W. Chrisinger. Keeping SNAP in Line with Global Evidence on Food Security. N Engl J Med 2024;391:873-875.

1
NEJM Interview: Erin Fuse Brown on the potential implications of recent Supreme Court decisions for health law and policy. 12:24

2M ago12:24

12:24

Erin Fuse Brown is a professor of health services, policy, and practice at the Brown University School of Public Health and a member of the Journal’s Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.E. Sachs and E.C. Fuse Brown. Supreme Power — The Loss of Judicial Deference to Healt…

1
When Patients Be Fibbin’ 36:27

2M ago36:27

36:27

Atrial fibrillation can be a tricky thing to manage in the ED. Sometimes it is not always clear if you should treat it, how you should treat it, or if it’s even safe to treat. In this episode, Ray Isenburg and host Will Smith discuss the basics of AFib, how to treat it (both chemically and/or electrically), when is it safe to treat, and how to dete…

1
NEJM at ESC — Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk 2:51

2M ago2:51

2:51

Did you miss the ESC Congress 2024? In a series of audio interviews (featured below), Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESC — Finerenone in Heart Failure for Mildly Reduced or Preserved Ejection Fraction 3:28

2M ago3:28

3:28

Did you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Have a listen! Visit NEJM.org to read the latest research.

1
NEJM at ESC — Asundexian versus Apixaban in Patients with Atrial Fibrillation 3:48

2M ago3:48

3:48

Did you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease 4:08

2M ago4:08

4:08

Did you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESC — Invasive versus Conservative Strategy for Older Patients with Myocardial Infarction 3:12

2M ago3:12

3:12

Did you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

Podcast Berbaloi untuk Didengar

Podcast Emergency Medicine Residents Association

Podcast Berbaloi untuk Didengar

1
EMRA*Cast

Emergency Medicine Residents' Association

1
NEJM Interviews

NEJM Group

1
AEMEarlyAccess's podcast

Brown University Emergency Medicine, Academic Emergency Medicine/SAEM

1
Transition to Attending-hood 23:15

1
NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity. 21:26

1
Views from Program Leadership 24:34

1
NEJM Interview: Jean Nachega on the mpox Public Health Emergency of International Concern. 9:20

1
Navigating Leadership in Emergency Medicine 16:33

1
NEJM Interview: Jonathan Oberlander on the implications of the 2024 U.S. elections for health care reform. 8:47

1
NEJM Interview: Abigail Cutler on providing training in abortion care to Ob/Gyn residents amid legal restrictions. 10:12

1
NEJM Interview: Charles Weijer on the potential benefits and ethical challenges associated with pragmatic and cluster RCTs. 11:56

1
Acetaminophen Overdose: Updated Guidance 20:01

1
NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma 2:58

1
NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors 2:56

1
NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma 3:11

1
NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer 3:44

1
NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma 3:41

1
NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer 3:25

1
NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer 3:23

1
NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer 2:21

1
NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer 2:50

1
NEJM at ESMO — Ponsegromab in Cancer Cachexia 2:37

1
NEJM Interview: Benjamin Chrisinger on proposed changes to the Supplemental Nutrition Assistance Program and other options for promoting improved health. 9:11

1
NEJM Interview: Erin Fuse Brown on the potential implications of recent Supreme Court decisions for health law and policy. 12:24

1
When Patients Be Fibbin’ 36:27

1
NEJM at ESC — Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk 2:51

1
NEJM at ESC — Finerenone in Heart Failure for Mildly Reduced or Preserved Ejection Fraction 3:28

1
NEJM at ESC — Asundexian versus Apixaban in Patients with Atrial Fibrillation 3:48

1
NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease 4:08

1
NEJM at ESC — Invasive versus Conservative Strategy for Older Patients with Myocardial Infarction 3:12

Panduan Rujukan Pantas